BridgeMD
New treatment option for Chonic Stroke Patients With Motor Impairment of Upper Limb
Official title Impact of rTMS on BCI Control in Upper Limb Motor Rehabilitation of Patients With Chronic Stroke
ClinicalTrials.gov ID: NCT06951035
What this study is testing
- What it's testing
- Cerebrovascular accidents (strokes) are a major public health issue. Stroke is the 3rd leading cause of death and the leading cause of disability and loss of autonomy.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- Single Stroke older than 6 months
- Distal motor deficit of the upper limb (UE-FMA score \< 53) with visible extension of the fingers (Medical Research Council (mRC) score ≥ 2)
- Right-handed
- Between 18 and 85 years of age
- Having given their written consent
You likely can't join if
- Patient under tutorship or guardianship, under safeguard of justice, deprived of liberty, pregnant or breast feeding women
- Life-threatening pathologies or compromising follow-up during the study period
- Trouble of understanding : score below 12/15 in the Boston Diagnostic Aphasia Examination (BDAE) order execution test
- Fixed spasticity of finger or carpal flexors (mAS score = 4) or botulinum toxin injection less than 12 weeks old in the forearm or hand
- History of degenarative neurological pathology or craniectomy
- Deficient upper limb skin lesion preventing use of mucle stimulation
See the full eligibility criteria
- Single Stroke older than 6 months
- Distal motor deficit of the upper limb (UE-FMA score \< 53) with visible extension of the fingers (Medical Research Council (mRC) score ≥ 2)
- Right-handed
- Between 18 and 85 years of age
- Having given their written consent
- Patient under tutorship or guardianship, under safeguard of justice, deprived of liberty, pregnant or breast feeding women
- Life-threatening pathologies or compromising follow-up during the study period
- Trouble of understanding : score below 12/15 in the Boston Diagnostic Aphasia Examination (BDAE) order execution test
- Fixed spasticity of finger or carpal flexors (mAS score = 4) or botulinum toxin injection less than 12 weeks old in the forearm or hand
- History of degenarative neurological pathology or craniectomy
- Deficient upper limb skin lesion preventing use of mucle stimulation
- Skin lesion of the scalp preventing EEG placement
- Participation in biomedical therapeutic research that may affect the recovery of the deficient hand during the study
- Patient who has previously participated in a therapeutic study rTMS (excluding single shock) or a BCI
- Patient who does not wish to be informed of a brain abnormality discovered accidentally on MRI
The study team makes the final eligibility decision.
Where it's taking place
- Paris, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.